Literature DB >> 23289712

The hunger hormone ghrelin in cachexia.

Alessio Molfino, Gianfranco Gioia, Maurizio Muscaritoli.   

Abstract

Cachexia is characterized by reduced food intake, muscle and adipose tissue loss associated with increased energy expenditure. Cachexia is highly prevalent and represents one of the main causes of increased morbidity, mortality and reduced quality of life in chronic diseases. Ghrelin plays an important role in stimulating and controlling hunger and maintaining energy homeostasis acting on central nervous system and on peripheral tissues. Most of the studies have been conducted in experimental settings and in cancer and uremic patients, showing interesting results in the treatment of cachexia. Further investigations are mandatory to obtain more definitive and conclusive results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23289712     DOI: 10.1517/14712598.2013.748031

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  3 in total

Review 1.  Cancer cachexia, recent advances, and future directions.

Authors:  Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 2.  Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Authors:  Jawed A Siddiqui; Ramesh Pothuraju; Maneesh Jain; Surinder K Batra; Mohd W Nasser
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-25       Impact factor: 10.680

3.  Acylated and unacylated ghrelin inhibit atrophy in myotubes co-cultured with colon carcinoma cells.

Authors:  Xianliang Zeng; Sizeng Chen; Yang Yang; Zhao Ke
Journal:  Oncotarget       Date:  2017-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.